Rift Valley fever vaccines: current and future needs

Baptiste Dungu, Baratang A. Lubisi, Tetsuro Ikegami

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

Rift Valley fever (RVF) is a zoonotic mosquito-borne bunyaviral disease associated with high abortion rates, neonatal deaths, and fetal malformations in ruminants, and mild to severe disease in humans. Outbreaks of RVF cause huge economic losses and public health impacts in endemic countries in Africa and the Arabian Peninsula. A proper vaccination strategy is important for preventing or minimizing outbreaks. Vaccination against RVF is not practiced in many countries, however, due to absence or irregular occurrences of outbreaks, despite serological evidence of RVF viral activity. Nonetheless, effective vaccination strategies, and functional national and international multi-disciplinary networks, remain crucial for ensuring availability of vaccines and supporting execution of vaccination in high risk areas for efficient response to RVF alerts and outbreaks.

Original languageEnglish (US)
Pages (from-to)8-15
Number of pages8
JournalCurrent Opinion in Virology
Volume29
DOIs
StatePublished - Apr 1 2018

ASJC Scopus subject areas

  • Virology

Fingerprint Dive into the research topics of 'Rift Valley fever vaccines: current and future needs'. Together they form a unique fingerprint.

  • Cite this